Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Allergy ; 73(2): 379-386, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-28857182

RESUMO

BACKGROUND: Cow's milk allergy (CMA) is one of the most common food allergies in children. Epigenetic mechanisms have been suggested to play a role in CMA pathogenesis. We have shown that DNA methylation of Th1/Th2 cytokine genes and FoxP3 affects CMA disease course. Preliminary evidence suggests that also the miRNome could be implicated in the pathogenesis of allergy. Main study outcome was to comparatively evaluate miRNome in children with CMA and in healthy controls. METHODS: Peripheral blood mononuclear cells were obtained from children aged 4-18 months: 10 CMA patients, 9 CMA patients who outgrew CMA, and 11 healthy controls. Small RNA libraries were sequenced using a next-generation sequencing-based approach. Functional assessment of IL-4 expression was also performed. RESULTS: Among the miRNAs differently expressed, 2 were upregulated and 14 were downregulated in children with active CMA compared to healthy controls. miR-193a-5p resulted the most downregulated miRNA in children with active CMA compared to healthy controls. The predicted targets of miR-193a-5p resulted upregulated in CMA patients compared to healthy controls. Peripheral blood CD4+ T cells transfected with a miR193a-5 inhibitor showed a significant upregulation of IL-4 mRNA and its protein expression. Children who outgrew CMA showed miRNA-193a-5p level, and its related targets expression, similar to that observed in healthy controls. CONCLUSIONS: Our results suggest that miR-193a-5p is a post-transcriptional regulator of IL-4 expression and could have a role in IgE-mediated CMA. This miRNA could be a novel diagnostic and therapeutic target for this common form of food allergy in childhood.


Assuntos
MicroRNAs/imunologia , Hipersensibilidade a Leite/imunologia , Feminino , Humanos , Lactente , Masculino , MicroRNAs/sangue , Hipersensibilidade a Leite/sangue , Reação em Cadeia da Polimerase
2.
Benef Microbes ; 9(1): 165-172, 2018 Jan 29.
Artigo em Inglês | MEDLINE | ID: mdl-29065709

RESUMO

Cow's milk fermented with Lactobacillus paracasei CBA L74 (FM-CBAL74) exerts a preventive effect against infectious diseases in children. We evaluated if this effect is at least in part related to a direct modulation of non-immune and immune defence mechanisms in human enterocytes. Human enterocytes (Caco-2) were stimulated for 48 h with FM-CBAL74 at different concentrations. Cell growth was assessed by colorimetric assay; cell differentiation (assessed by lactase expression), tight junction proteins (zonula occludens1 and occludin), mucin 2, and toll-like receptor (TRL) pathways were analysed by real-time PCR; innate immunity peptide synthesis, beta-defensin-2 (HBD-2) and cathelicidin (LL-37) were evaluated by ELISA. Mucus layer thickness was analysed by histochemistry. FMCBA L74 stimulated cell growth and differentiation, tight junction proteins and mucin 2 expression, and mucus layer thickness in a dose-dependent fashion. A significant stimulation of HBD-2 and LL-37 synthesis, associated with a modulation of TLR pathway, was also observed. FM-CBAL74 regulates non-immune and immune defence mechanisms through a direct interaction with the enterocytes. These effects could be involved in the preventive action against infectious diseases demonstrated by this fermented product in children.


Assuntos
Produtos Fermentados do Leite/microbiologia , Enterócitos/efeitos dos fármacos , Lacticaseibacillus paracasei/fisiologia , Probióticos/farmacologia , Peptídeos Catiônicos Antimicrobianos/biossíntese , Células CACO-2 , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Enterócitos/citologia , Enterócitos/imunologia , Enterócitos/ultraestrutura , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Mucina-2/genética , Ocludina/genética , Junções Íntimas/genética , Junções Íntimas/metabolismo , Receptores Toll-Like/genética , Proteína da Zônula de Oclusão-1/genética , beta-Defensinas/biossíntese , Catelicidinas
3.
Benef Microbes ; 6(2): 225-32, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25851101

RESUMO

Food allergy (FA) is a major health issue for children living in Western countries. At this time the only proven treatment for FA is elimination of offender antigen from the diet. It is becoming clear that the development of gut microbiota exerts a profound influence on immune system maturation and tolerance acquisition. Increasing evidence suggests that perturbations in gut microbiota composition of infants are implicated in the pathogenesis of FA. These findings have unveiled new strategies to prevent and treat FA using probiotics bacteria or bacterial substance to limit T-helper (Th)/Th2 bias, which changes during the disease course. Selected probiotics administered during infancy may have a role in the prevention and treatment of FA. Lactobacillus rhamnosus GG (LGG) is the most studied probiotic in this field. Administration of LGG in early life have a role in FA prevention. Preliminary evidence shows that LGG accelerates oral tolerance acquisition in cow's milk allergic infants. We are understanding the mechanisms elicited by LGG and metabolites in influencing food allergen sensitization. A deeper definition of these mechanisms is opening the way to new immunotherapeutics for children affected by FA that can efficiently limit the disease burden.


Assuntos
Hipersensibilidade Alimentar/tratamento farmacológico , Lacticaseibacillus rhamnosus/fisiologia , Probióticos/administração & dosagem , Animais , Criança , Pré-Escolar , Ensaios Clínicos como Assunto , Hipersensibilidade Alimentar/microbiologia , Hipersensibilidade Alimentar/prevenção & controle , Humanos , Lactente , Resultado do Tratamento
4.
Cornea ; 19(3): 343-7, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10832696

RESUMO

PURPOSE: To describe the treatment of Schnyder's crystalline dystrophy (SCD) with excimer laser phototherapeutic keratectomy (PTK). METHODS: Chart review of three patients (four eyes) with SCD treated with PTK between March 1992 and December 1998. Pre- and posttreatment visual acuity, subjective glare, photophobia, manifest refraction, ultrasound pachymetry, hyperopic shift, and biomicroscopic findings were studied. Brightness acuity testing (BAT) was evaluated in two eyes. RESULTS: Four eyes were treated during the study period. The average best corrected visual acuity (BCVA) improved from 20/175 to 20/40 under bright conditions. All patients reported subjective improvement in glare and photophobia. No visually significant recurrence was observed during the follow-up period which ranged from seven months to three years. The mean spherical equivalent refractive shift was +3.28 diopter (D). One patient developed irregular astigmatism from an eccentric ablation. No vision threatening complications were observed. CONCLUSION: PTK can be effective at improving visual symptoms in patients with SCD. It can be a useful therapeutic alternative to lamellar or penetrating keratoplasty in these patients.


Assuntos
Córnea/cirurgia , Distrofias Hereditárias da Córnea/cirurgia , Ceratectomia Fotorrefrativa , Córnea/patologia , Córnea/fisiopatologia , Distrofias Hereditárias da Córnea/patologia , Distrofias Hereditárias da Córnea/fisiopatologia , Ofuscação , Humanos , Lasers de Excimer , Masculino , Pessoa de Meia-Idade , Fotofobia/fisiopatologia , Refração Ocular , Acuidade Visual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA